Management
Paul van der Schueren, President, Chief Executive Officer (CEO)
Paul founded Oligovax, negotiated the partnership contract with Assistance Publique - Hôpitaux de Paris and participated in arranging several financing rounds. Paul brings his experience in growing and running start-ups and is in charge of financial and legal matters. He is a graduate of Solvay MBA.Pr Antoine Carpentier, Scientific Advisor
Inventor of stabilized oligonucleotides with anti-tumor action, Antoine (MD, PhD) is Professor in Paris Hospital (AP-HP), Head of Department of Neuro-Oncology (Saint-Louis Hospital) and Oligovax's scientific interlocutor).Contact
© Copyright Oligovax 2018 - All Rights Reserved
Mentions légales : Site et contenus propriétés d'Oligovax
Création et intégration : Justine Gélis / Justincreations.fr - Hébergeur OVH
Mentions légales : Site et contenus propriétés d'Oligovax
Création et intégration : Justine Gélis / Justincreations.fr - Hébergeur OVH